Asymchem, a global contract development and manufacturing organization (CDMO), has unveiled an integrated commercial supply matrix for TIDES (Peptides and Oligonucleotides) at its TJ4 site, combining ...
NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.
With a focus on specialty medicines, growth is driven by pharmaceutical needs for cost-effective, efficient production and ...
From crystallographers' beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why st ...
Allergy affects more than one billion people worldwide—and the number is rising. For many, it means mild symptoms such as ...
When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched carbon structures-points where the molecular chain forks in a specific direction ...
Professor Gyu Rie Lee of the Department of Biological Sciences successfully designed artificial proteins that selectively ...
As semaglutide’s patent expires in India, over 50 pharma brands including Sun Pharma, Dr Reddy’s and Cipla are racing to ...
Supporting cell communication processes is critical for maintaining human performance and long-term health.”— Hunter ...
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company developing ...
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company developing inflammation ...
Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results